These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Low-molecular-weight heparin (LMWH) in the treatment of thrombosis. Holzheimer RG. Eur J Med Res; 2004 Apr 30; 9(4):225-39. PubMed ID: 15210403 [Abstract] [Full Text] [Related]
7. [Treatment of venous thrombosis in cancer patients: practical aspects]. Laza-Achille M, Desruennes E, Di Palma M. Bull Cancer; 2006 Mar 01; 93(3):271-81. PubMed ID: 16567314 [Abstract] [Full Text] [Related]
9. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. Lee AY, Levine MN, Baker RI, Bowden C, Kakkar AK, Prins M, Rickles FR, Julian JA, Haley S, Kovacs MJ, Gent M, Randomized Comparison of Low-Molecular-Weight Heparin versus Oral Anticoagulant Therapy for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer (CLOT) Investigators. N Engl J Med; 2003 Jul 10; 349(2):146-53. PubMed ID: 12853587 [Abstract] [Full Text] [Related]
10. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery. Colwell C, Mouret P. Semin Vasc Med; 2005 Aug 10; 5(3):266-75. PubMed ID: 16123914 [Abstract] [Full Text] [Related]
12. Oral anticoagulant therapy in venous thromboembolism. Cosmi B, Palareti G. Semin Vasc Med; 2003 Aug 10; 3(3):303-14. PubMed ID: 15199464 [Abstract] [Full Text] [Related]
13. Use of low-molecular-weight heparins in the treatment and secondary prevention of cancer-associated thrombosis. Grande C, Caparro M. Semin Oncol Nurs; 2005 Nov 10; 21(4 Suppl 1):41-9. PubMed ID: 16360897 [Abstract] [Full Text] [Related]
14. Management of thromboembolism in patients with cancer. Viale PH. Oncol Nurs Forum; 1999 Nov 10; 26(10):1625-32; quiz 1633-4. PubMed ID: 10573679 [Abstract] [Full Text] [Related]